Use of Postexposure Prophylaxis After Occupational Exposure toZaire ebolavirus | Zendy

Karen K. Wong | Zendy; Richard T. Davey | Zendy; Angela Hewlett | Zendy; Colleen S. Kraft | Zendy; Aneesh K. Mehta | Zendy; Mark J. Mulligan | Zendy; Allison Beck | Zendy; William Dorman | Zendy; Christopher J. Kratochvil | Zendy; Lilin Lai | Zendy; Tara N. Palmore | Zendy; Susan Rogers | Zendy; Philip W. Smith | Zendy; Anthony F. Suffredini | Zendy; Mark Wolcott | Zendy; Ute Ströher | Zendy; Timothy M. Uyeki | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of Postexposure Prophylaxis After Occupational Exposure toZaire ebolavirus

Author(s) -

Karen K. Wong,

Richard T. Davey,

Angela Hewlett,

Colleen S. Kraft,

Aneesh K. Mehta,

Mark J. Mulligan,

Allison Beck,

William Dorman,

Christopher J. Kratochvil,

Lilin Lai,

Tara N. Palmore,

Susan Rogers,

Philip W. Smith,

Anthony F. Suffredini,

Mark Wolcott,

Ute Ströher,

Timothy M. Uyeki

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw256

Subject(s) - ebolavirus , medicine , ebola virus , post exposure prophylaxis , virology , pre exposure prophylaxis , occupational exposure , virus , environmental health , human immunodeficiency virus (hiv) , men who have sex with men , syphilis

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research